Capstan Medical
Capstan Medical Raises $110M Series C | Cardiac Surgical Robotics
Capstan Medical Closes $110M for Surgical Robotics
Capstan Medical, a company creating minimally invasive technologies to treat heart valve disorders, has raised $110 million in Series C funding.
The round was led by Eclipse Ventures with participation from Intuitive Ventures, Meritech Capital, and Gideon Strategic Partners.
Key Highlights
- Total funding to date: $141.4 million
- Advanced surgical robotics for cardiac procedures
- Backed by Intuitive Surgical venture arm
Company Overview
Capstan Medical is developing advanced surgical robotics and instrumentation for minimally invasive cardiac procedures, focusing on heart valve repair and replacement.
Company Info
Investors (3)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free